Summary by Moomoo AI
On March 14, 2024, Dongsun Changjiang Pharmaceutical (stock code: 01558.HK) issued a transaction disclosure regarding its privatization transaction. Under Rule 22 of the Hong Kong Code of Acquisitions and Mergers, CICC Financial Trading Limited conducted the relevant securities transactions on 13 March 2024. The transaction consists of the purchase and sale of a total of 620,000 shares involving the amounts of $6,689,424.91 and $6,691,689.35, respectively, at a price of $10.7894 to $10.7930 per share. CICC Financial Trading Limited is an associate of the Contracting Party and is exempt from self-dealing status. The transaction is a proprietary transaction and is completed before the close of the morning trading session on the trading day following the transaction due to the client's needs.